BRPI0405662A - Emplastros contendo turobuterol - Google Patents

Emplastros contendo turobuterol

Info

Publication number
BRPI0405662A
BRPI0405662A BR0405662-0A BRPI0405662A BRPI0405662A BR PI0405662 A BRPI0405662 A BR PI0405662A BR PI0405662 A BRPI0405662 A BR PI0405662A BR PI0405662 A BRPI0405662 A BR PI0405662A
Authority
BR
Brazil
Prior art keywords
turobuterol
adhesive layer
release control
plasters
containing plasters
Prior art date
Application number
BR0405662-0A
Other languages
English (en)
Inventor
Sadanobu Shirai
Masahiro Yamaji
Osamu Yoshimoto
Mamoru Naruse
Kenichi Hattori
Takako Sueda
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of BRPI0405662A publication Critical patent/BRPI0405662A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Adhesive Tapes (AREA)

Abstract

"EMPLASTROS CONTENDO TUROBUTEROL". A presente invenção refere-se a um emplastro contendo turobuterol em concentração baixa e tendo a capacidade de controle de liberação estável, preparado através de laminação de uma camada adesiva consistindo em uma borracha, uma resina adesiva e um plastificante na parte traseira, onde 1 a 4% p/p de turobuterol na concentração menor como um ingrediente ativo e 0,1 a 3% p/p de um ácido graxo superior como um agente de controle de liberação de droga estão contidos na camada adesiva.
BR0405662-0A 2003-06-20 2004-06-16 Emplastros contendo turobuterol BRPI0405662A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003176799 2003-06-20
PCT/JP2004/008777 WO2004112770A1 (ja) 2003-06-20 2004-06-16 ツロブテロール含有貼付剤

Publications (1)

Publication Number Publication Date
BRPI0405662A true BRPI0405662A (pt) 2005-07-19

Family

ID=33534909

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0405662-0A BRPI0405662A (pt) 2003-06-20 2004-06-16 Emplastros contendo turobuterol

Country Status (15)

Country Link
US (1) US8029820B2 (pt)
EP (1) EP1557164A4 (pt)
JP (1) JP4647490B2 (pt)
KR (1) KR101184810B1 (pt)
CN (1) CN100409843C (pt)
AU (1) AU2004249045B2 (pt)
BR (1) BRPI0405662A (pt)
CA (1) CA2494568C (pt)
IL (1) IL166668A (pt)
MX (1) MXPA05001951A (pt)
NO (1) NO342694B1 (pt)
NZ (1) NZ538372A (pt)
TW (1) TWI324523B (pt)
WO (1) WO2004112770A1 (pt)
ZA (1) ZA200501085B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101925355B (zh) 2008-01-28 2013-05-29 帝国制药株式会社 含芬太尼的外用贴剂
CN101590028B (zh) * 2009-04-16 2011-06-01 中国人民解放军第二军医大学 包含妥洛特罗的水凝胶贴剂及其制备方法
KR100973233B1 (ko) * 2010-01-25 2010-07-30 신신제약 주식회사 툴로부테롤을 함유하는 경피흡수제제
WO2012103016A2 (en) * 2011-01-26 2012-08-02 Csi Gmbh Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
WO2012103015A2 (en) * 2011-01-27 2012-08-02 Csi Gmbh Extended-release beta agonist/steroid transdermal patches and methods for using the same
SI3054908T1 (en) * 2013-10-10 2018-07-31 F. Hoffmann-La Roche Ag Carrier system for the body to be worn and the production process
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
CN110433146B (zh) * 2018-05-03 2022-03-15 中国医学科学院药物研究所 一种妥洛特罗晶体贮库型透皮贴剂及其制备方法
WO2021024105A1 (en) * 2019-08-07 2021-02-11 Azista Industries Pvt Ltd Tulobuterol transdermal patch and it's process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310716A (ja) 1986-07-02 1988-01-18 Teijin Ltd β−刺激薬外用剤
JPH0785596B2 (ja) 1988-03-09 1995-09-13 三菱電機株式会社 遠隔監視制御システム
DE4002281A1 (de) * 1990-01-26 1991-08-01 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit dem wirkstoff tulobuterol
US5080469A (en) 1990-03-29 1992-01-14 Hughes Aircraft Company Optical limiter including optical convergence and absorbing body with inhomogeneous distribution of reverse saturable material
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
BR9610943A (pt) 1995-10-17 1999-12-21 Nitto Denko Corp Preparação de tulobuterol do tipo de absorção percutânea e processo para a produção da mesma.
JP3930984B2 (ja) 1997-12-12 2007-06-13 日東電工株式会社 経皮吸収型製剤
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut

Also Published As

Publication number Publication date
KR101184810B1 (ko) 2012-09-20
WO2004112770A1 (ja) 2004-12-29
CN1697652A (zh) 2005-11-16
NO342694B1 (no) 2018-07-09
KR20060018207A (ko) 2006-02-28
AU2004249045B2 (en) 2009-07-16
EP1557164A4 (en) 2006-03-15
CA2494568C (en) 2012-08-14
JPWO2004112770A1 (ja) 2006-07-27
IL166668A (en) 2011-05-31
US8029820B2 (en) 2011-10-04
IL166668A0 (en) 2006-01-15
MXPA05001951A (es) 2005-04-28
CN100409843C (zh) 2008-08-13
AU2004249045A2 (en) 2004-12-29
TW200503788A (en) 2005-02-01
NZ538372A (en) 2007-07-27
TWI324523B (en) 2010-05-11
CA2494568A1 (en) 2004-12-29
ZA200501085B (en) 2005-08-30
EP1557164A1 (en) 2005-07-27
JP4647490B2 (ja) 2011-03-09
US20050220852A1 (en) 2005-10-06
NO20050875L (no) 2005-02-18
AU2004249045A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
BRPI0507683A8 (pt) dose unitária de formulação farmacêutica com liberação controlada, seu processo de preparação e uso de um copolímero de poli(acrilato de etila, metacrilato de metila) neutro
AR111679A2 (es) Formulación farmacéutica de liberación controlada, procesos, usos, método
ATE373494T1 (de) Hauthaftkleber zur verwendung als kissen oder pflaster
ATE375142T1 (de) Medizinische aerosolformulierungen
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
AR097045A2 (es) Sistema terapéutico transdérmico
CO5570656A2 (es) Liberacin controlada de una sustancia activa a un entorno rico en grasa
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
ECSP099387A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
BRPI0414907A (pt) formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
HRP20050828B1 (hr) Uv-stabilni transdermalni flaster
BR9806470B1 (pt) preparação do tipo absorção percutánea.
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
BRPI0405662A (pt) Emplastros contendo turobuterol
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
TW200635616A (en) Organic compounds
IL192611A0 (en) Biologically active composition comprising ethylcellulose
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
AR040287A1 (es) Plataforma para formulaciones transdermicas (pft)
BRPI0701785A (pt) composto de 1,3-benzodioxol e emprego do mesmo
TW200719902A (en) Solid transdermal therapeutic system with uv absorber
NO20080420L (no) Formulering med forlenget frigivelse av aktive bestanddeler med pH-avhengig loselighet

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11, 13, 25 E 32 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]